Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Victoria slams Australian federal government for inaction on PrEP

The Victorian Government has announced it will provide additional funding towards the state’s pre-exposure prophylaxis (PrEP) trial to give nearly 4,000 people access to the HIV prevention pill. Victoria called on the federal government to take action and provide additional funding for high-risk people to access PrEP now. However, these calls were not responded to.

Published
27 March 2017
From
Star Observer
Frame PrEP as part of a ‘healthy sex life’ for better adherence

Brief, empowering messaging around pre-exposure prophylaxis (PrEP) can lead to better medication adherence, new research has found. When PrEP counselors framed PrEP as part of a healthy sex life, new PrEP clients were significantly more likely to have high levels of adherence to the medication. This was true even among demographics that typically struggle with adherence including young people and people of color.

Published
27 March 2017
From
BETA blog
Trialling PrEP: What happened to the NHS PrEP trial?

When NHS England announced at the start of December 2016 that they’d be funding a new large-scale PrEP trial, many people thought that they’d be able to access PrEP in the spring. More than 3 months later, and the trial has not even started to recruit. Dr Will Nutland from PrEPster.info gives an update about what’s going on with the trial.

Published
23 March 2017
From
Boyz
Welsh report says HIV prevention drug 'highly effective'

PrEP has "clear potential" to prevent people catching the virus, a Welsh Government-commissioned report has said. It is not currently available on the Welsh NHS.

Published
22 March 2017
From
BBC
This HIV Drug Is Making a Difference. Now Republicans Want to Make It Unaffordable

Republican's plan to replace the ACA would complicate PrEP access, particularly for low-income Americans in the 31 states, plus the District of Columbia, that adopted the Medicaid expansion.

Published
09 March 2017
From
Money
Thousands of HIV negative Kenyans to be put on ARVs to prevent infection

Thousands of HIV negative Kenyans will for the first time in history be placed on daily ARV pills this month to prevent infection. The pills will be given to those at high risk of contracting the virus, the Health ministry said on Tuesday. Martin Sirengo, head of the National AIDS and STI Control Programme, said trained health workers will assess who qualifies for this treatment, technically known as Pre-exposure prophylaxis (Prep).

Published
07 March 2017
From
The Star, Kenya
PrEP approved but difficulties remain says New Zealand AIDS Foundation

Approved access to the PrEP medication Truvada is being cautiously welcomed by the NZ AIDS Foundation which says difficulties remain in accessing and using the drug to ward off HIV infection and a poor level of training of GPs.

Published
06 March 2017
From
Gay NZ
What we know about the new England PrEP trial

@teamPrEPster, and other HIV advocate groups, will be keeping a watchful eye on development of the trial, not least to ensure that there are no further delays to its implementation.

Published
27 February 2017
From
Prepster
Mr Gay NZ defends his view that having unprotected sex with HIV can be safe

The new Mr Gay New Zealand, who is HIV positive, is defending having unprotected sex, saying he always informs sexual partners of his health status. He said he only had unprotected sex with HIV positive men or HIV negative men who he knew were on Pre-exposure prophylaxis (PrEP), which was a pill that reduced the risk of them getting HIV.

Published
21 February 2017
From
New Zealand Herald
PrEP uses contributes to decline in STI incidence among MSM

Results from a modeling study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2017 indicated that the use of pre-exposure prophylaxis for HIV prevention in addition to routine screening and treatment of sexually transmitted infections, or STIs, could reduce the incidence of STIs among men who have sex with men, even when condom use was reduced.

Published
20 February 2017
From
Healio
← First12345...83Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.